92 related articles for article (PubMed ID: 1578365)
1. Human cytochrome P450 metabolism of teniposide and etoposide.
Relling MV; Evans R; Dass C; Desiderio DM; Nemec J
J Pharmacol Exp Ther; 1992 May; 261(2):491-6. PubMed ID: 1578365
[TBL] [Abstract][Full Text] [Related]
2. O-demethylation of epipodophyllotoxins is catalyzed by human cytochrome P450 3A4.
Relling MV; Nemec J; Schuetz EG; Schuetz JD; Gonzalez FJ; Korzekwa KR
Mol Pharmacol; 1994 Feb; 45(2):352-8. PubMed ID: 8114683
[TBL] [Abstract][Full Text] [Related]
3. DNA breakage in human lung carcinoma cells and nuclei that are naturally sensitive or resistant to etoposide and teniposide.
Long BH; Musial ST; Brattain MG
Cancer Res; 1986 Aug; 46(8):3809-16. PubMed ID: 3015377
[TBL] [Abstract][Full Text] [Related]
4. Human cytochrome P450 maximal activities in pediatric versus adult liver.
Blanco JG; Harrison PL; Evans WE; Relling MV
Drug Metab Dispos; 2000 Apr; 28(4):379-82. PubMed ID: 10725303
[TBL] [Abstract][Full Text] [Related]
5. Biotransformation of caffeine, paraxanthine, theophylline, and theobromine by polycyclic aromatic hydrocarbon-inducible cytochrome(s) P-450 in human liver microsomes.
Campbell ME; Grant DM; Inaba T; Kalow W
Drug Metab Dispos; 1987; 15(2):237-49. PubMed ID: 2882985
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of Teniposide (VM26) and etoposide (VP16-213) in children with cancer.
Evans WE; Sinkule JA; Crom WR; Dow L; Look AT; Rivera G
Cancer Chemother Pharmacol; 1982; 7(2-3):147-50. PubMed ID: 7083455
[TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy of the epipodophyllotoxin derivatives, teniposide and etoposide. A pharmacodynamic rationale?
Allen LM; Tejada F; Okonmah AD; Nordqvist S
Cancer Chemother Pharmacol; 1982; 7(2-3):151-6. PubMed ID: 7083456
[TBL] [Abstract][Full Text] [Related]
8. Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease.
George J; Murray M; Byth K; Farrell GC
Hepatology; 1995 Jan; 21(1):120-8. PubMed ID: 7806144
[TBL] [Abstract][Full Text] [Related]
9. Metabolic activation of dacarbazine by human cytochromes P450: the role of CYP1A1, CYP1A2, and CYP2E1.
Reid JM; Kuffel MJ; Miller JK; Rios R; Ames MM
Clin Cancer Res; 1999 Aug; 5(8):2192-7. PubMed ID: 10473105
[TBL] [Abstract][Full Text] [Related]
10. [O-methyl 14C]naproxen O-demethylase activity in human liver microsomes: evidence for the involvement of cytochrome P4501A2 and P4502C9/10.
Rodrigues AD; Kukulka MJ; Roberts EM; Ouellet D; Rodgers TR
Drug Metab Dispos; 1996 Jan; 24(1):126-36. PubMed ID: 8825200
[TBL] [Abstract][Full Text] [Related]
11. N,N',N''-triethylenethiophosphoramide (thio-TEPA) oxygenation by constitutive hepatic P450 enzymes and modulation of drug metabolism and clearance in vivo by P450-inducing agents.
Ng SF; Waxman DJ
Cancer Res; 1991 May; 51(9):2340-5. PubMed ID: 1707751
[TBL] [Abstract][Full Text] [Related]
12. Involvement of human liver cytochrome P450 3A in vinblastine metabolism: drug interactions.
Zhou-Pan XR; Sérée E; Zhou XJ; Placidi M; Maurel P; Barra Y; Rahmani R
Cancer Res; 1993 Nov; 53(21):5121-6. PubMed ID: 8221648
[TBL] [Abstract][Full Text] [Related]
13. Single- and double-strand DNA breakage and repair in human lung adenocarcinoma cells exposed to etoposide and teniposide.
Long BH; Musial ST; Brattain MG
Cancer Res; 1985 Jul; 45(7):3106-12. PubMed ID: 3839166
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of drug metabolism in rat liver slices: IV. Comparison of ethoxycoumarin clearance by liver slices, isolated hepatocytes, and hepatic microsomes from rats pretreated with known modifiers of cytochrome P-450 activity.
Carlile DJ; Hakooz N; Houston JB
Drug Metab Dispos; 1999 Apr; 27(4):526-32. PubMed ID: 10101148
[TBL] [Abstract][Full Text] [Related]
15. Identification of enzymes involved in the metabolism of atrazine, terbuthylazine, ametryne, and terbutryne in human liver microsomes.
Lang DH; Rettie AE; Böcker RH
Chem Res Toxicol; 1997 Sep; 10(9):1037-44. PubMed ID: 9305587
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of the cytochrome P450 enzymes involved in N-dealkylation of propafenone: molecular base for interaction potential and variable disposition of active metabolites.
Botsch S; Gautier JC; Beaune P; Eichelbaum M; Kroemer HK
Mol Pharmacol; 1993 Jan; 43(1):120-6. PubMed ID: 8423765
[TBL] [Abstract][Full Text] [Related]
17. Species differences in the toxicity and cytochrome P450 IIIA-dependent metabolism of digitoxin.
Eberhart DC; Gemzik B; Halvorson MR; Parkinson A
Mol Pharmacol; 1991 Nov; 40(5):859-67. PubMed ID: 1944247
[TBL] [Abstract][Full Text] [Related]
18. Variables in human liver microsome preparation: impact on the kinetics of l-alpha-acetylmethadol (LAAM) n-demethylation and dextromethorphan O-demethylation.
Nelson AC; Huang W; Moody DE
Drug Metab Dispos; 2001 Mar; 29(3):319-25. PubMed ID: 11181502
[TBL] [Abstract][Full Text] [Related]
19. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1.
Gallagher EP; Wienkers LC; Stapleton PL; Kunze KL; Eaton DL
Cancer Res; 1994 Jan; 54(1):101-8. PubMed ID: 8261428
[TBL] [Abstract][Full Text] [Related]
20. Identification of the human liver microsomal cytochrome P450s involved in the metabolism of N-nitrosodi-n-propylamine.
Teiber JF; Hollenberg PF
Carcinogenesis; 2000 Aug; 21(8):1559-66. PubMed ID: 10910959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
